A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy

Cavazzano-Calvo, 2004, The future of gene therapy, Nature, 427, 779, 10.1038/427779a Schmidt-Wolf, 2003, Non-viral and hybrid vectors in human gene therapy: an update, Trend. Mol. Med., 9, 67, 10.1016/S1471-4914(03)00005-4 Kichler, 2004, Gene transfer with modified polyethylenimines, J. Gene Med., 6, S3, 10.1002/jgm.507 Li, 2004, CNS gene transfer mediated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA: a comparison with polyethylenimine/DNA complexes, Gene Ther., 11, 109, 10.1038/sj.gt.3302135 Putnam, 2001, Polymer-based gene delivery with low cytotoxicity by a unique balance of side chain termini, Proc. Natl. Acad. Sci. USA, 98, 1200, 10.1073/pnas.98.3.1200 Godbey, 1999, Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery, Proc. Natl. Acad. Sci. USA, 96, 5177, 10.1073/pnas.96.9.5177 Boussif, 1995, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine, Proc. Natl. Acad. Sci. USA, 92, 7297, 10.1073/pnas.92.16.7297 Clamme, 2003, Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy, Biochim. Biophys. Acta Biomembr., 1617, 52, 10.1016/j.bbamem.2003.09.002 Fischer, 1999, A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity, Pharm. Res., 16, 1273, 10.1023/A:1014861900478 Florea, 2002, Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated Cos-1 cell cultures, AAPS PharmSci., 4, 10.1208/ps040312 Clamme, 2003, Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence spectroscopy, Biophys. J., 84, 1960, 10.1016/S0006-3495(03)75004-8 Klemm, 1998, Effects of polyethyleneimine on endocytosis and lysosome stability, Biochem. Pharmacol., 56, 41, 10.1016/S0006-2952(98)00098-7 Martin, 1996, Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/Ced-3 protease activity, J. Biol. Chem., 271, 28753, 10.1074/jbc.271.46.28753 Waring, 1999, Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis, Cell Death Differ., 6, 624, 10.1038/sj.cdd.4400540 Bonneau, 2000, Spermine oxidation leads to necrosis with plasma membrane phosphatidylserine redistribution in mouse leukemia cells, Exp. Cell Res., 259, 23, 10.1006/excr.2000.4974 Jones, 2004, pDMAEMA is internalised by endocytosis but does not physically disrupt endosomes, J. Controlled Release, 96, 379, 10.1016/j.jconrel.2004.02.011 Mislick, 1996, Evidence for the role of proteoglycans in cation-mediated gene transfer, Proc. Natl. Acad. Sci. USA, 93, 12349, 10.1073/pnas.93.22.12349 Wong, 2000, Hierarchical self-assembly of F-actin and cationic lipid complexes: stacked three-layer tubule networks, Science, 288, 2035, 10.1126/science.288.5473.2035 Martin, 1995, Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by over-expression of Bcl-2 and Abl, J. Exp. Med., 182, 1545, 10.1084/jem.182.5.1545 Bortner, 1999, Caspase independent/dependent regulation of K+, cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis, J. Biol. Chem., 274, 21953, 10.1074/jbc.274.31.21953 Dinsdale, 1999, Redistribution of cytochrome c precedes the caspase-dependent formation of ultra-condensed mitochondria, with a reduced inner membrane potential, in apoptotic monocytes, Am. J. Pathol., 155, 607, 10.1016/S0002-9440(10)65156-5 Ricci, 2004, Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain, Cell, 117, 773, 10.1016/j.cell.2004.05.008 Gogvadze, 2001, Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax, J. Biol. Chem., 276, 19066, 10.1074/jbc.M100614200 Scarlett, 1997, Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition, FEBS Lett., 418, 282, 10.1016/S0014-5793(97)01391-4 Letai, 2002, Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics, Cancer Cell, 2, 183, 10.1016/S1535-6108(02)00127-7 Kircheis, 1999, Polycation-based DNA complexes for tumor-targeted gene delivery in vivo, J. Gene Med., 1, 111, 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.0.CO;2-Y Omidi, 2003, Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells, J. Drug Targeting, 11, 311, 10.1080/10611860310001636908 Anderson, 2003, Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery, Angew. Chem. Int. Ed., 42, 3153, 10.1002/anie.200351244 Moghimi, 2005, Nanomedicine: current status and future prospects, FASEB J., 19, 311, 10.1096/fj.04-2747rev Moghimi, 2004, Cellular distribution of nonionic micelles, Science, 303, 626, 10.1126/science.303.5658.626